Usana Health Sciences Inc Stock Price, News & Analysis

USANA (USNA) President and CEO Jim Brown has been elected to the Board of Directors of the Direct Selling Association (DSA), where he will serve a three-year term. Brown brings over 25 years of leadership experience, including 19 years at USANA in various executive roles. The DSA, serving as the national trade association for direct selling companies, reported that the industry generated $36.7 billion in retail sales in 2023, with 6.1 million entrepreneurs operating in the U.S. DSA CEO David Grimaldi expressed enthusiasm about Brown's appointment, citing his significant industry experience and potential impact.

USANA (USNA) has secured five prestigious Best of State awards in Utah, including the coveted Best of State Statue (BOSS) for Science & Technology Overall. The company's Research and Development team earned its fifth BOSS award since 2008, while USANA CellSentials and Celavive skincare maintained their winning streaks for the ninth and eighth consecutive years respectively in the Dietary Supplement and Personal Care Products categories. The USANA Foundation received its first Best of State award for Private Sector Community Development, recognizing its contribution of tens of millions of meals and critical aid globally. The company's R&D team also won for the seventh time, highlighting USANA's commitment to innovation and product excellence. These awards, judged by over 100 experts, evaluate achievement, innovation, and contribution to Utah's quality of life.

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting National Outdoors Month in June by sharing insights from his personal experiences and book 'All the Right Reasons'. Guest, drawing from his Montana upbringing near Lake Blaine, outlines five key benefits of outdoor engagement: physical health improvements, mental well-being enhancement, stress reduction, creativity boosts, and social bonding opportunities. The initiative aligns with USANA's holistic wellness approach, with Guest encouraging people to disconnect from digital devices and reconnect with nature. His book's proceeds support feeding hungry children, with each purchase providing 40 meals. USANA, established in 1992, operates in 25 countries as a global health and wellness products leader.

USANA (USNA) has released its fifth annual sustainability report for 2024, showcasing significant progress in environmental, social, and product initiatives. Key achievements include 51% women in leadership positions and 84% engagement in global employee surveys. The company's Salt Lake campus achieved 58% energy use from renewable sources. Environmental efforts resulted in 157% operational waste diversion and savings of over 300,000 supplement bottles worth of plastic. The USANA Foundation provided 12.3 million meals, while employees contributed 2,690 volunteer hours. The company invested $11.6 million in R&D and launched seven new products. All employees completed Good Manufacturing Practices training, demonstrating USANA's commitment to quality standards.

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest shares key success strategies on Executive Coaching Day, drawing from his bestselling book "All the Right Reasons." Guest outlines four fundamental principles for professional and personal success:

• Growth Mindset: Developing abilities through effort and learning
• Power of Collaboration: Working together toward shared goals
• Vision: Maintaining clear direction and purpose
• Resilience: Adapting and recovering from setbacks

Guest illustrates these principles through personal stories, including how his parents rebuilt their lumber mill after a devastating fire. His book "All the Right Reasons" supports charitable causes, with each purchase providing 40 meals to hungry children.

USANA Health Sciences has achieved a significant recognition as its Celavive Postbiotic Rescue Serum was selected as a winner in the Good Housekeeping 2025 Beauty Awards. The announcement came on April 28, 2025, highlighting the company's innovation in skincare products.

The award-winning serum is designed as a daily calming treatment specifically formulated for stressed-out and blemish-prone skin. The product's key features include a lightweight formula enriched with microbiome-friendly postbiotics and soothing botanicals, aimed at visibly resetting and balancing skin appearance while enhancing moisture levels.

Chief Commercial Officer Brent Neidig credited the company's product and R&D teams for their dedication in developing the postbiotic line, emphasizing the significant effort invested in creating this award-winning skincare solution.

USANA Health Sciences (NYSE: USNA) reported Q1 2025 financial results with net sales of $250 million, up 10% year-over-year. The company saw mixed performance with net earnings declining 43% to $9.4 million and diluted EPS falling to $0.49 from $0.86.

Key metrics include Adjusted EBITDA of $30 million (-10% YoY) and Direct Selling Active Customers of 459,000. The company's Hiya division showed strong performance with 224,000 Active Monthly Subscribers and $37 million in net sales.

USANA reiterated its fiscal year 2025 outlook, projecting consolidated net sales of $920 million to $1.0 billion and adjusted diluted EPS of $2.35 to $3.00. The company repurchased 399,000 shares for $12 million during Q1, with $49 million remaining under current authorization.

Management noted potential challenges from international trade uncertainties and tariffs, particularly regarding raw materials trade between the US and China, though these impacts are not reflected in current guidance.

USANA Health Sciences has announced positive results from a clinical study of its Celavive Resurfacing Serum. The study, involving 33 women aged 39-65 with mild to moderate skin concerns, demonstrated significant skin improvements in just two weeks.

The 12-week study revealed notable improvements including:

• 15.8% reduction in fine lines appearance
• 11.6% reduction in pores appearance
• 23% reduction in acute visible hyperpigmentation
• 8.9% improvement in apparent skin clarity
• 8.6% improvement in skin radiance

The serum, containing alpha/beta hydroxy acids, niacinamide, peptides, and bakuchiol (a natural retinol alternative), was well-tolerated by all participants. Notably, 81.8% of participants reported the best skin feeling in a long time, and 97% would recommend the product.

USANA Health Sciences (NYSE:USNA) has announced its schedule for first quarter 2025 earnings release, set for Tuesday, April 22, 2025, after market close. The company will post its Management Commentary document on their Investor Relations website, followed by a conference call with analysts and institutional investors on Wednesday, April 23, 2025, at 11:00 a.m. Eastern Time.

USANA develops and manufactures nutritional supplements, functional foods and personal care products, distributed through direct sales to Associates and Preferred Customers across 24 countries. The company maintains a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company specializing in clean-label products.